Bulis Veronica Sanchez, VP and Corporate Controller at Lyell Immunopharma ($LYEL), sold shares on the open market four times in the last year, totaling $83,901. Her most recent sale occurred on February 10, 2026. These sales rank 9,809th among 11,678 individual insiders, compared to an average sale value of $8.6 million across 6.4 transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2026 | Lyell Immunopharma, Inc. | $LYEL | Bulis Veronica Sanchez | VP, Corporate Controller | A | Common Stock | 8750 | $0.00 | 15,891.0000 | 21,218,217 | 122.53% | 0.04% |
| Feb. 10, 2026 | Lyell Immunopharma, Inc. | $LYEL | Bulis Veronica Sanchez | VP, Corporate Controller | S | Common Stock | 254 | $23.12 | 15,637.0000 | 21,218,217 | 1.60% | 0.00% |
| Dec. 24, 2025 | Lyell Immunopharma, Inc. | $LYEL | Bulis Veronica Sanchez | VP, Corporate Controller | S | Common Stock | 1136 | $38.67 | 8,077.0000 | 21,218,217 | 12.33% | 0.01% |
| Dec. 30, 2025 | Lyell Immunopharma, Inc. | $LYEL | Bulis Veronica Sanchez | VP, Corporate Controller | S | Common Stock | 936 | $32.32 | 7,141.0000 | 21,218,217 | 11.59% | 0.00% |
| Nov. 10, 2025 | Lyell Immunopharma, Inc. | $LYEL | Bulis Veronica Sanchez | VP, Corporate Controller | S | Common Stock | 239 | $16.10 | 9,213.0000 | 295,228,868 | 2.53% | 0.00% |